EWM
IBRX icon

Empirical Wealth Management’s ImmunityBio IBRX Stock Holding History

Empirical Wealth Management’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,000
Closed -$12K – 336
2019
Q3 		$12K Buy
+10,000
New +$12.4K ﹤0.01% 284

Other funds holding IBRX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Empirical Wealth Management's IBRX Position: Q4 2019 in Review

Empirical Wealth Management sold out of ImmunityBio (IBRX) in Q4 2019, closing a stake of 10,000 shares — an estimated $12K sold.

Empirical Wealth Management first reported a position in IBRX in Q3 2019 and held it in 1 quarter. The position peaked at $12K in Q3 2019. 47 funds tracked by Wall St. Rank hold IBRX as of Q4 2019.

  • Empirical Wealth Management reported no remaining ImmunityBio position as of Q4 2019 after selling out during the quarter.
  • Empirical Wealth Management sold 10,000 ImmunityBio shares in Q4 2019, an estimated $12K.
  • Empirical Wealth Management first reported a position in ImmunityBio in Q3 2019 and held it in 1 quarter.
  • Empirical Wealth Management's ImmunityBio position peaked at $12K in Q3 2019.
  • 47 funds tracked by Wall St. Rank held ImmunityBio as of Q4 2019.

Based on Empirical Wealth Management's 13F filing for Q4 2019, filed 13 Feb 2020.